Evidence map›Paper›PMID 39334881›Full record

ArticleBiomolecules2024

A Nanobody of PEDV S1 Protein: Screening and Expression in

Zhipeng Hao, Xufeng Dong, Zhongtao Zhang, Zhihua Qin

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhipeng HaoCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Xufeng DongCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Zhongtao ZhangCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Zhihua QinCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.

Funding

Shandong Province "Double-Hundred Talent Plan" WST2019013
6 · The paper itself

Abstract

Porcine epidemic diarrhea virus (PEDV) has caused significant economic losses to the pig farming industry in various countries for a long time. Currently, there are no highly effective preventive or control measures available. Research into the pathogenic mechanism of PEDV has shown that it primarily causes infection by binding the S protein to the CD13 (APN) receptor on the membrane of porcine intestinal epithelial cells. The S1 region contains three neutralization epitopes and multiple receptor-binding domains, which are closely related to viral antigenicity and ad-sorption invasion. Nanobodies are a type of single-domain antibody that have been discovered in recent years. They can be expressed on a large scale through prokaryotic expression systems, which makes them cost-effective, stable, and less immunogenic. This study used a phage display library of nanobodies against the PEDV S1 protein. After three rounds of selection and enrichment, the DNA sequence of the highly specific nanobody S1Nb1 was successfully obtained. To obtain soluble nanobody S1Nb1, its DNA sequence was inserted into the vector Pcold and a solubility-enhancing SUMO tag was added. The resulting recombinant vector, Pcold-SUMO-S1Nb1, was then transformed into

Indexed as

Escherichia coliPorcine epidemic diarrhea virusSingle-Domain AntibodiesAnimalsGene ExpressionPeptide LibrarySpike Glycoprotein, CoronavirusSwinePeptide LibrarySingle-Domain AntibodiesSpike Glycoprotein, CoronavirusEscherichia colinanobodiesPEDVsoluble expression

Identifiers

PMID39334881
PMCPMC11430113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.